Live recombinant Salmonella Typhi vaccines constructed to investigate the role of rpoS in eliciting immunity to a heterologous antigen
about
Salmonella as a vaccine delivery vehicleThe route less taken: pulmonary models of enteric Gram-negative infectionLive-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent DeliveryThe aspartate-semialdehyde dehydrogenase of Edwardsiella ictaluri and its use as balanced-lethal system in fish vaccinologyEvaluation of YadC protein delivered by live attenuated Salmonella as a vaccine against plagueThe delicate balance in genetically engineering live vaccines.Engineering a portable riboswitch-LacP hybrid device for two-way gene regulation.Making Common Sense of Vaccines: An Example of Discussing the Recombinant Attenuated Salmonella Vaccine with the PublicDevelopment of Streptococcus pneumoniae Vaccines Using Live VectorsEvaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challengeUse of Ensure® nutrition shakes as an alternative formulation method for live recombinant Attenuated Salmonella Typhi vaccines.Novel protein-based pneumococcal vaccines administered with the Th1-promoting adjuvant IC31 induce protective immunity against pneumococcal disease in neonatal mice.Fur-regulated iron uptake system of Edwardsiella ictaluri and its influence on pathogenesis and immunogenicity in the catfish hostIn vitro Intestinal Mucosal Epithelial Responses to Wild-Type Salmonella Typhi and Attenuated Typhoid VaccinesNew technologies in developing recombinant attenuated Salmonella vaccine vectors.Evaluation of regulated delayed attenuation strategies for Salmonella enterica serovar Typhi vaccine vectors in neonatal and infant mice.A colanic acid operon deletion mutation enhances induction of early antibody responses by live attenuated Salmonella vaccine strains.Live Attenuated Human Salmonella Vaccine Candidates: Tracking the Pathogen in Natural Infection and Stimulation of Host ImmunityRapid, sensitive recovery of recombinant attenuated Salmonella enterica serovar Typhi vaccine strains from human blood.Salmonella enterica as a vaccine carrier.Serotype-independent pneumococcal vaccines.Increased persistence of Salmonella enterica serovar Typhi in the presence of Acanthamoeba castellaniiPreclinical efficacy and safety of the Ty21a vaccine strain for intravesical immunotherapy of non-muscle-invasive bladder cancer.Salmonella enterica serovar Choleraesuis vector delivering SaoA antigen confers protection against Streptococcus suis serotypes 2 and 7 in mice and pigs.Salmonella Vaccines: Conduits for Protective Antigens.Conversion of RpoS- Attenuated Salmonella enterica Serovar Typhi Vaccine Strains to RpoS+ Improves Their Resistance to Host Defense Barriers.
P2860
Q27011946-0FA256F2-72D2-4414-A058-8BD7CAC87999Q27691303-C6B91163-AAC5-424E-8C9A-AC78F5BF556DQ28084076-9B5F9934-C35C-4C9F-9807-3463BD0047D3Q30994198-10A76577-F335-4BAA-8688-CB24CE98291BQ33637474-329F20EE-07C2-48E2-9C1A-E25CFD36D0FAQ33801051-4253A15C-79EB-411F-B40D-A2D8747B8CD6Q33976285-1CD151E9-DAF5-4003-8905-63B432F2FC84Q34030095-C2B7F5CC-68FF-4DF3-9656-6264FE2041CAQ34316015-F2BF4410-1A69-488A-9642-C67D03F926BEQ34457319-F4C94140-FE2D-46DF-84C6-3B72761CD588Q35338804-0730114A-8BE2-4733-A418-977DBE33511DQ35665351-943C43EE-65EB-49A5-BAEE-CA40DE098356Q36211164-C0BEBA2E-05A0-4AFD-8AAA-158D0EB32F45Q36601934-856146AE-2208-4FF1-9069-389E62B292FCQ36653379-72AEB723-5ACE-4C20-9DCF-75F50F68FD35Q36911282-531C6156-5E0E-4D8A-A15B-C124D22EF6CFQ37123734-16E52FAE-5985-4FDE-B075-1EEFC06CBAB8Q37429384-0B5732D4-479C-41F3-B096-B919F2F7EFE1Q37469650-03D48AC0-0DC9-41B9-82E4-BDD50BE24D75Q37970705-40C09BD5-86C8-4F7A-913C-1BC626B37A41Q38069943-6B8D91FF-29C6-4896-8FA2-A7206233262DQ38957557-8DE59914-7016-4B89-86CE-FB486CB408ABQ38961435-2A7C7402-84E9-494B-9981-E7B7AB163636Q47158759-B0A4AAB2-A38B-4A35-8595-8C8360F8CD44Q49644946-A7FFAA7A-4E6B-4E8F-97C4-A097C155FA1DQ53704376-82F876A5-DCC9-4D54-86C8-1070173B1311
P2860
Live recombinant Salmonella Typhi vaccines constructed to investigate the role of rpoS in eliciting immunity to a heterologous antigen
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Live recombinant Salmonella Ty ...... nity to a heterologous antigen
@ast
Live recombinant Salmonella Ty ...... nity to a heterologous antigen
@en
type
label
Live recombinant Salmonella Ty ...... nity to a heterologous antigen
@ast
Live recombinant Salmonella Ty ...... nity to a heterologous antigen
@en
prefLabel
Live recombinant Salmonella Ty ...... nity to a heterologous antigen
@ast
Live recombinant Salmonella Ty ...... nity to a heterologous antigen
@en
P2093
P2860
P1433
P1476
Live recombinant Salmonella Ty ...... nity to a heterologous antigen
@en
P2093
Huoying Shi
Javier Santander
Karen E Brenneman
Kenneth L Roland
Patti Senechal
Roy Curtiss
Shifeng Wang
Soo-Young Wanda
P2860
P304
P356
10.1371/JOURNAL.PONE.0011142
P407
P577
2010-06-18T00:00:00Z